Prognosis of patients with diffuse large B cell lymphoma not reaching complete response or relapsing after frontline chemotherapy or immunochemotherapy

A retrospective study was performed to assess the outcome of patients with diffuse large B cell lymphoma (DLBCL) who did not achieve complete response or who relapsed before and after the use of rituximab. Clinical features and outcome of 816 (425 M/391 F; median age 63 years) patients diagnosed fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Rovira, Jordina, Valera, Alexandra, Colomo, Lluis, Setoain, Xavier, Rodríguez, Sonia, Martínez-Trillos, Alejandra, Giné, Eva, Dlouhy, Ivan, Magnano, Laura, Gaya, Anna, Martínez, Daniel, Martínez, Antonio, Campo, Elías, López-Guillermo, Armando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374121/
https://www.ncbi.nlm.nih.gov/pubmed/25501975
http://dx.doi.org/10.1007/s00277-014-2271-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374121/
https://www.ncbi.nlm.nih.gov/pubmed/25501975
http://dx.doi.org/10.1007/s00277-014-2271-1

Ejemplares similares